These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22743031)

  • 21. Ventricular late potentials in systemic sclerosis: relationship with skin involvement.
    Paradiso M; Di Franco M; Musca A; Basili S; Riccieri V; Paoletti V; De Matteis A; Mammarella A
    J Rheumatol; 2002 Jul; 29(7):1388-92. PubMed ID: 12136893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study of the prevalence of systemic sclerosis in northeast England.
    Allcock RJ; Forrest I; Corris PA; Crook PR; Griffiths ID
    Rheumatology (Oxford); 2004 May; 43(5):596-602. PubMed ID: 14872101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of prognostic factors for skin sclerosis and lung function in Japanese patients with early systemic sclerosis: a multicentre prospective observational study.
    Hasegawa M; Asano Y; Endo H; Fujimoto M; Goto D; Ihn H; Inoue K; Ishikawa O; Kawaguchi Y; Kuwana M; Muro Y; Ogawa F; Sasaki T; Takahashi H; Tanaka S; Takehara K; Sato S
    Rheumatology (Oxford); 2012 Jan; 51(1):129-33. PubMed ID: 22072085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti-topoisomerase I antibodies and those with anticentromere antibody.
    Komura K; Yanaba K; Ogawa F; Shimizu K; Takehara K; Sato S
    Clin Exp Dermatol; 2008 May; 33(3):329-32. PubMed ID: 18312458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis.
    Hara T; Ogawa F; Muroi E; Komura K; Takenaka M; Hasegawa M; Fujimoto M; Sato S
    J Rheumatol; 2008 Mar; 35(3):451-7. PubMed ID: 18203319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie).
    Tiev KP; Diot E; Clerson P; Dupuis-Siméon F; Hachulla E; Hatron PY; Constans J; Cirstéa D; Farge-Bancel D; Carpentier PH
    J Rheumatol; 2009 Jul; 36(7):1470-6. PubMed ID: 19487271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies in patients with systemic sclerosis and cancer: a case-control study.
    Derk CT; Sakkas LI; Rasheed M; Artlett C; Jimenez SA
    J Rheumatol; 2003 Sep; 30(9):1994-6. PubMed ID: 12966604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients.
    Rodriguez-Reyna TS; Hinojosa-Azaola A; Martinez-Reyes C; Nuñez-Alvarez CA; Torrico-Lavayen R; García-Hernández JL; Cabiedes-Contreras J
    Autoimmunity; 2011 Nov; 44(7):576-84. PubMed ID: 21875377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship of dyspnoea to function and quality of life in systemic sclerosis.
    Baron M; Sutton E; Hudson M; Thombs B; Markland J; Pope J; Robinson D; Jones N; Docherty P; Abu-Hakima M; LeClercq S; Smith D; Mathieu JP
    Ann Rheum Dis; 2008 May; 67(5):644-50. PubMed ID: 17728334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered diurnal rhythm of prolactin in systemic sclerosis.
    Hilty C; Brühlmann P; Sprott H; Gay RE; Michel BA; Gay S; Neidhart M
    J Rheumatol; 2000 Sep; 27(9):2160-5. PubMed ID: 10990228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature.
    Ferri C; De Angelis R; Giuggioli D; Bajocchi G; Dagna L; Zanframundo G; Foti R; Cacciapaglia F; Cuomo G; Ariani A; Rosato E; Guiducci S; Girelli F; Riccieri V; Zanatta E; Bosello S; Cavazzana I; Ingegnoli F; De Santis M; Murdaca G; Abignano G; Romeo N; Della Rossa A; Caminiti M; Iuliano A; Ciano G; Beretta L; Bagnato G; Lubrano E; De Andres I; Giollo A; Saracco M; Agnes C; Lumetti F; Spinella A; Magnani L; Campochiaro C; De Luca G; Codullo V; Visalli E; Masini F; Gigante A; Bellando-Randone S; Pellegrino G; Pigatto E; Lazzaroni MG; Franceschini F; Generali E; Mennillo G; Barsotti S; Mariano GP; Calabrese F; Furini F; Vultaggio L; Parisi S; Peroni CL; Rozza D; Zanetti A; Carrara G; Landolfi G; Scirè CA; Bianchi G; Fusaro E; Sebastiani GD; Govoni M; D'Angelo S; Cozzi F; Doria A; Iannone F; Salvarani C; Matucci-Cerinic M;
    Autoimmun Rev; 2022 Oct; 21(10):103159. PubMed ID: 35908642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serological and clinical profile of systemic sclerosis: analysis in a cohort of patients from a single center in Northern Italy.
    Priora M; Manetta T; Scarati M; Parisi S; Laganà A; Peroni CL; Bruzzone M; Borrelli R; Rende M; Mengozzi G; Fusaro E
    G Ital Dermatol Venereol; 2018 Feb; 153(1):33-38. PubMed ID: 27055150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature.
    Ferri C; Sebastiani M; Lo Monaco A; Iudici M; Giuggioli D; Furini F; Manfredi A; Cuomo G; Spinella A; Colaci M; Govoni M; Valentini G
    Autoimmun Rev; 2014 Oct; 13(10):1026-34. PubMed ID: 25182204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demography, clinical and laboratory features of systemic sclerosis in a Malaysian rheumatology centre.
    Pagalavan L; Ong SG
    Med J Malaysia; 2007 Jun; 62(2):117-21. PubMed ID: 18705442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
    Hayakawa I; Hasegawa M; Takehara K; Sato S
    Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations.
    Kodera M; Hayakawa I; Komura K; Yanaba K; Hasegawa M; Takehara K; Sato S
    J Rheumatol; 2005 Apr; 32(4):629-36. PubMed ID: 15801017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors for lung function in systemic sclerosis: prospective study of 105 cases.
    Gilson M; Zerkak D; Wipff J; Dusser D; Dinh-Xuan AT; Abitbol V; Chaussade S; Legmann P; Kahan A; Allanore Y
    Eur Respir J; 2010 Jan; 35(1):112-7. PubMed ID: 19541715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.